Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.

Faster global financial news!

Regeneron Pharmaceuticals, Inc.

REGN NASDAQHealthcare ★★★★★
Market Cap $75.74B
Latest Earnings Above forecast↑
Date
Jul 30, 2026
ET
EPS Est.
10.16
EPS Actual
14.29
Revenue Est.
$3.82B
Revenue Actual
$4.29B
Next Earnings Report
Date
Oct 28, 2026 · Wed
ET Oct 28, 2026 · Wed
Time
10/28 10:00-13:30
Pre-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
15.99
Revenue Est.
$4.54B
Company Overview
Regeneron Pharmaceuticals, Inc. (ticker REGN) is listed on NASDAQ with a market cap of about $75.74B. Its next earnings report (FY2026 Q3) is expected on Oct 28, 2026 (ET), Pre-market, with consensus EPS of 15.99. In the last 15 reported quarters, EPS beat consensus estimates 13 times.
Actual EPS TrendRecently15Term · Feb 3, 2023 → Jul 30, 2026
Feb 3, 2023Range: 8.22 ~ 14.29Jul 30, 2026
Earnings History
Date Fiscal Period EPS Est. EPS Actual Revenue Est. Revenue Actual
Jul 30, 2026 -- 10.16 Above forecast↑14.29 $3.82B $4.29B
Apr 29, 2026 -- 8.91 Above forecast↑9.47 $3.48B $3.61B
Jan 30, 2026 -- 10.74 Above forecast↑11.44 $3.81B $3.88B
Oct 28, 2025 -- 9.65 Above forecast↑11.83 $3.59B $3.75B
Aug 1, 2025 -- 8.43 Above forecast↑12.89 $3.29B $3.68B
Apr 29, 2025 -- 8.62 Below forecast↓8.22 $3.25B $3.03B
Feb 4, 2025 -- 11.21 Above forecast↑12.07 $3.74B $3.79B
Oct 31, 2024 -- 11.69 Above forecast↑12.46 $3.67B $3.72B
Aug 1, 2024 -- 10.61 Above forecast↑11.56 $3.38B $3.55B
May 2, 2024 -- 10.17 Below forecast↓9.55 $3.23B $3.15B
Feb 2, 2024 -- 10.73 Above forecast↑11.86 $3.29B $3.43B
Nov 2, 2023 -- 10.72 Above forecast↑11.59 $3.22B $3.36B
Aug 3, 2023 -- 9.84 Above forecast↑10.24 $3.02B $3.16B
May 4, 2023 -- 9.25 Above forecast↑10.09 $3B $3.16B
Feb 3, 2023 -- 10.03 Above forecast↑12.56 $3.12B $3.41B
Original Filings (SEC)
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
Current Location: Home > Economic Calendar > Earnings Calendar > REGN